Journal: Integrated multi-omics profiling reveals novel molecular biomarkers and pathways associated with Fragile X-associated tremor/ataxia syndrome
Product Description:
Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder affecting carriers of premutation expansions (55-200 CGG repeats) in the fragile X messenger ribonucleoprotein 1 (FMR1) gene. Despite its clinical significance, FXTAS currently lacks reliable molecular markers for disease monitoring and evaluation of therapeutic efficacy.
Keyword(s):
FXTAS; Fragile X- associated tremor/ataxia syndrome, amine; biomarkers; lipidomic; metabolomics, multi-omics; premutation
Product/Publication Type(s):
Peer-reviewed publications in scholarly journals Published/In Press
Target Audience:
Professionals
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A